Abiopharma

🔍 Girolamo Todd C (Executive)

Company: PROKIDNEY CORP. (PROK)

Report Date: 2026-06-12

Detailed Transactions and Holdings:

• Acquired 163,857 shares of Class A Common Stock (Direct)
  Date: 2026-06-12 | Code: C | equity_swap_involved: false | shares_owned_after: 327,713.00 | transaction_form_type: 4
• Sold 163,857 shares of Class B Common Stock (Derivative)
  Date: 2026-06-12 | Code: C | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Sold 163,857 shares of Common Units in ProKidney Holdings, LLC (Derivative)
  Date: 2026-06-12 | Code: C | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F3, F3

Footnotes:

• F1: The Class B Common Stock and the Common Units in ProKidney Holdings LLC (a "Common Unit") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Amended and Restated Exchange Agreement, dated as of July 1, 2025, and and the Second Amended and Restated Limited Liability Company Agreement of ProKidney Holdings, LLC, each Class B Common Stock, together with a paired Common Unit, may be exchanged for Class A Common stock on a one-for-one basis.
• F2: The Class B Common Stock were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the "Business Combination Agreement"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Common Stock do not expire.
• F3: The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire.